Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiwei Yang

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|February 28, 2018
Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stabilityJingyuan Tang, Feng Wang, Gong Cheng, et al.
Frontiers in Oncology|November 1, 2021
CircFAM114A2 Promotes Cisplatin Sensitivity <i>via</i> miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial CarcinomaJiancheng Lv, Zijian Zhou, Jingzi Wang, et al.
Oncotarget|December 10, 2017
The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinomaXiao Li, Jingyuan Tang, Wen Huang, et al.
Cell Biology and Toxicology|May 14, 2022
CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathwayDexiang Feng, Jiancheng Lv, Kai Li, et al.
Frontiers in Immunology|December 10, 2021
Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot StudyJun Tao, Li Sun, Zijie Wang, et al.
Oncotarget|December 17, 2017
Associations between <i>HVEM/LIGHT/BTLA/CD160</i> polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipientsZijie Wang, Ke Wang, Haiwei Yang, et al.
World Journal of Urology|November 6, 2017
Polymorphisms of nucleotide factor of activated T cells cytoplasmic 2 and 4 and the risk of acute rejection following kidney transplantationZijie Wang, Haiwei Yang, Shuhui Si, et al.
Current Drug Metabolism|June 28, 2019
Association of Genetic Variants in CYP3A4, CYP3A5, CYP2C8, and CYP2C19 with Tacrolimus Pharmacokinetics in Renal Transplant RecipientsZijie Wang, Ming Zheng, Haiwei Yang, et al.
Frontiers in Immunology|April 30, 2021
Impaired ATG16L-Dependent Autophagy Promotes Renal Interstitial Fibrosis in Chronic Renal Graft Dysfunction Through Inducing EndMT by NF-κB Signal PathwayZeping Gui, Chuanjian Suo, Zijie Wang, et al.
Frontiers in Immunology|March 18, 2021
Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney TransplantationHengcheng Zhang, Zijie Wang, Jiayi Zhang, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Journal of Experimental & Clinical Cancer Research : CR|February 28, 2018
Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stabilityJingyuan Tang, Feng Wang, Gong Cheng, et al.
Frontiers in Oncology|November 1, 2021
CircFAM114A2 Promotes Cisplatin Sensitivity <i>via</i> miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial CarcinomaJiancheng Lv, Zijian Zhou, Jingzi Wang, et al.
Oncotarget|December 10, 2017
The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinomaXiao Li, Jingyuan Tang, Wen Huang, et al.
Cell Biology and Toxicology|May 14, 2022
CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathwayDexiang Feng, Jiancheng Lv, Kai Li, et al.
Frontiers in Immunology|December 10, 2021
Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot StudyJun Tao, Li Sun, Zijie Wang, et al.
Oncotarget|December 17, 2017
Associations between <i>HVEM/LIGHT/BTLA/CD160</i> polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipientsZijie Wang, Ke Wang, Haiwei Yang, et al.
World Journal of Urology|November 6, 2017
Polymorphisms of nucleotide factor of activated T cells cytoplasmic 2 and 4 and the risk of acute rejection following kidney transplantationZijie Wang, Haiwei Yang, Shuhui Si, et al.
Current Drug Metabolism|June 28, 2019
Association of Genetic Variants in CYP3A4, CYP3A5, CYP2C8, and CYP2C19 with Tacrolimus Pharmacokinetics in Renal Transplant RecipientsZijie Wang, Ming Zheng, Haiwei Yang, et al.
Frontiers in Immunology|April 30, 2021
Impaired ATG16L-Dependent Autophagy Promotes Renal Interstitial Fibrosis in Chronic Renal Graft Dysfunction Through Inducing EndMT by NF-κB Signal PathwayZeping Gui, Chuanjian Suo, Zijie Wang, et al.
Frontiers in Immunology|March 18, 2021
Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney TransplantationHengcheng Zhang, Zijie Wang, Jiayi Zhang, et al.
Pageof 12